William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Upgrades Kezer Life Sciences (KZR) to Outperform
-
William Blair Starts Corbus Pharmaceuticals (CRBP) at Outperform
-
William Blair Starts Skye Bioscience (SKYE) at Outperform
-
William Blair Starts Zealand Pharma A/S (ZEAL) at Market Perform
-
Form X-17A-5 WILLIAM BLAIR & COMPANY For: Dec 31
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31
-
William Blair encourage its clients to buy this fintech stock on recent weakness
-
CohnReznick Secures Strategic Growth Investment From Apax Funds
-
KEV Group Enters Next Phase with Five Arrows Following Successful Serent Capital Partnership
-
Driven Brands (DRVN) to Divest U.S. Car Wash Business for $385M
-
Driven Brands Announces Agreement to Divest U.S. Car Wash Business for $385 Million
-
Spartan Capital Securities Names Brian Duddy as Head of Capital Markets
-
Form 485APOS WILLIAM BLAIR FUNDS
-
William Blair Reiterates Outperform Rating on AAON Inc (AAON), Top Idea
-
Waystar Announces Pricing of Public Offering of Common Stock
-
Oxford Lane Capital Corp. Prices Public Offering of $165,000,000 7.95% Notes Due 2032
-
VestGen Wealth Partners Completes Buildout of C-Suite with Seasoned Executives and Dedicated Innovators
-
Carvana poised for strong Q4 as analysts see continued growth and profitability gains
-
Sauer Brands Completes Acquisition by Advent International
-
Frigid temperatures chill US single-family homebuilding; tariffs a potential drag
-
Oxford Lane Capital Corp. Announces Offering of Notes
-
Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus N
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
AE Industrial Establishes Commercial HVAC Services Platform with National Scale through Investment in United Building Solutions
-
William Blair Upgrades Parsons Corp. (PSN) to Outperform
-
Solid Biosciences (SLDB) Prices 35.74M Share Offering at $4.03/sh
-
Solid Biosciences Announces Pricing of Underwritten Offering
-
Karman Announces Closing of its Upsized Initial Public Offering, with Full Exercise of Over-Allotment Option
-
William Blair Reiterates Outperform Rating on Twilio (TWLO)
-
William Blair Reiterates Outperform Rating on Palo Alto Networks (PANW)
-
William Blair Reiterates Outperform Rating on Datadog (DDOG)
-
William Blair Reiterates Outperform Rating on CyberArk Software (CYBR)

